How does a small company such as NBS get institutions to buy into a secondary offering:
Rationally, Aegis would call different funds and explain how NBS will return 30-40%. This means potential announcements, upcoming events, etc..."without givivg out illegal info" (you get my point). So what does that mean for me and you.
We are still the sucker in this game, however riding on the coats of these institutions at 50 cents doen't sound like a bad play.
Just keep tight control of your account and have a target in mind and press the red button when you get there. Remember, even if you don't make evry dollar you can, it's better than losing.
It's at .50 because it's an emerging biotech company that has been putting things in place to be a world-class presence in the stem sphere. Huge two-pronged approach with its pipeline and contract manufacturing facilities. This is why big investors are getting in now. As super says, it's a long term play. Don't worry about the daily moves. Buy what you can afford to lose and hold on.
I like NBS and am Holding, but if we go up say 30% we are only back to where we started. Then what happens? Does that Big Investor sell for his 30% gain and it go back to .50?
Doesn't seem that it was such a great deal for anyone that has been here for a while!